Menta Capital’s ICU Medical ICUI Stock Holding History

Menta Capital’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-840	Closed	-$212K	–	697
2018 Q1	$212K	Sell	840 -120	-13%	-$28.2K	0.05%	556
2017 Q4	$207K	Buy	+960	New	+$194K	0.04%	567
2016 Q2	–	Sell	-5,400	Closed	-$562K	–	911
2016 Q1	$562K	Buy	5,400 +3,300	+157%	+$316K	0.08%	444
2015 Q4	$237K	Buy	+2,100	New	+$232K	0.03%	727

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Menta Capital's ICUI Position: Q2 2018 in Review

Menta Capital sold out of ICU Medical (ICUI) in Q2 2018, closing a stake of 840 shares — an estimated $212K sold.

Menta Capital first reported a position in ICUI in Q4 2015 and held it in 4 quarters. The position peaked at $562K in Q1 2016. 344 funds tracked by Wall St. Rank hold ICUI as of Q2 2018.

Menta Capital reported no remaining ICU Medical position as of Q2 2018 after selling out during the quarter.
Menta Capital sold 840 ICU Medical shares in Q2 2018, an estimated $212K.
Menta Capital first reported a position in ICU Medical in Q4 2015 and held it in 4 quarters.
Menta Capital's ICU Medical position peaked at $562K in Q1 2016.
344 funds tracked by Wall St. Rank held ICU Medical as of Q2 2018.

Based on Menta Capital's 13F filing for Q2 2018, filed 14 Aug 2018.